Scientists say Oxford Covid vaccine looks safe, induces immunity

A coronavirus vaccine created by the University of Oxford appears safe and induces a strong immune response within the body, scientists announced on Monday after the first phase of human trials.......

Tech, defence, energy: Key agenda for Modi-Biden talks

Prime Minister Narendra Modi and United States President Joe Biden during their talks next week are expected to touch on five broad areas of significance -- healthcare, technology, renewable......

DCGI approves mRNA Covid jab for 18 yrs & above; Covovax for 7-11 yrs

The Drugs Controller General of India on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use......

COVID vaccine likely to be available by first of 2021: Choubey

If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini......

Peregrine plans cancer drug trial in India

US drug research major Peregrine Pharmaceuticals Inc will conduct trials of its latest brain cancer drug-Cotara in India. The safety and efficacy study of this drug at seven clinical centres in the......

Actis plans research arm, multiple JVs

US-based biopharmaceutical company Actis Biologics Inc is setting up its wholly owned subsidiary in India in a move to make the country a hub for its clinical research and developmental......

Covid vaccine: Pharma firms ready expansion plans

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred......

TIL to pump $350 mn into global start-ups

Tata Industries, a promoter company of the Tata group, is ready to invest up to $350 million (about Rs 1,500 crore) in international start-up businesses. "We are looking at breakthrough......